Analysen zu AstraZeneca PLC
| 10.03.25 | AstraZeneca Buy | UBS AG | |
| 10.03.25 | AstraZeneca Buy | UBS AG | |
| 04.03.25 | AstraZeneca Outperform | Bernstein Research | |
| 26.02.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 26.02.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 26.02.25 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 20.02.25 | AstraZeneca Outperform | Bernstein Research | |
| 19.02.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 13.02.25 | AstraZeneca Buy | UBS AG | |
| 11.02.25 | AstraZeneca Outperform | Bernstein Research | |
| 10.02.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 06.02.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 03.02.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 21.01.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 15.01.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 13.01.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 07.01.25 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 07.01.25 | AstraZeneca Outperform | Bernstein Research | |
| 06.01.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 09.12.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 05.12.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 03.12.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 25.11.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 20.11.24 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 13.11.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 12.11.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 12.11.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 08.11.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 06.11.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 05.11.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 05.11.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 04.11.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 25.10.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 22.10.24 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.10.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 25.09.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 23.09.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 18.09.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 17.09.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 10.09.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 09.09.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 09.09.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 05.09.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 03.09.24 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 15.08.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 05.08.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 29.07.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 23.07.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 10.07.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 04.07.24 | AstraZeneca Buy | Goldman Sachs Group Inc. |
Aktuelle Aktienanalysen
| 19.09.25 | NORMA Group Buy | Warburg Research | |
| 19.09.25 | RENK Neutral | Goldman Sachs Group Inc. | |
| 19.09.25 | Rheinmetall Buy | Goldman Sachs Group Inc. | |
| 19.09.25 | Aumovio Buy | Deutsche Bank AG | |
| 19.09.25 | DHL Group Overweight | JP Morgan Chase & Co. | |
| 19.09.25 | Scout24 Outperform | RBC Capital Markets | |
| 19.09.25 | DHL Group Hold | Deutsche Bank AG | |
| 19.09.25 | FedEx Buy | Jefferies & Company Inc. | |
| 19.09.25 | K+S Neutral | JP Morgan Chase & Co. | |
| 19.09.25 | FedEx Overweight | JP Morgan Chase & Co. | |
| 19.09.25 | Continental Overweight | JP Morgan Chase & Co. | |
| 19.09.25 | Aumovio Overweight | JP Morgan Chase & Co. | |
| 19.09.25 | Ströer Overweight | JP Morgan Chase & Co. | |
| 18.09.25 | Scout24 Hold | Jefferies & Company Inc. | |
| 18.09.25 | Bechtle Buy | UBS AG | |
| 18.09.25 | Intel Neutral | UBS AG | |
| 18.09.25 | AUTO1 Outperform | RBC Capital Markets | |
| 18.09.25 | EssilorLuxottica Buy | Jefferies & Company Inc. | |
| 18.09.25 | Meta Platforms Overweight | JP Morgan Chase & Co. | |
| 18.09.25 | Redcare Pharmacy Buy | Jefferies & Company Inc. | |
| 18.09.25 | PUMA Halten | DZ BANK | |
| 18.09.25 | KRONES Buy | Jefferies & Company Inc. | |
| 18.09.25 | Evonik Hold | Jefferies & Company Inc. | |
| 18.09.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 18.09.25 | AstraZeneca Hold | Deutsche Bank AG | |
| 18.09.25 | Schneider Electric Buy | Deutsche Bank AG | |
| 18.09.25 | Pernod Ricard Buy | Jefferies & Company Inc. | |
| 18.09.25 | KRONES Buy | Deutsche Bank AG | |
| 18.09.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 18.09.25 | AB InBev Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 18.09.25 | Pernod Ricard Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 18.09.25 | Diageo Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 18.09.25 | EssilorLuxottica Outperform | RBC Capital Markets | |
| 18.09.25 | PUMA Hold | Deutsche Bank AG | |
| 18.09.25 | ProSiebenSat.1 Media Equal Weight | Barclays Capital | |
| 18.09.25 | KRONES Buy | Baader Bank | |
| 18.09.25 | PUMA Sector Perform | RBC Capital Markets | |
| 18.09.25 | adidas Outperform | RBC Capital Markets | |
| 18.09.25 | Fielmann Hold | Warburg Research | |
| 18.09.25 | Siemens Healthineers Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 18.09.25 | Allianz Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 18.09.25 | Air Liquide Buy | UBS AG | |
| 18.09.25 | KRONES Hold | Hauck Aufhäuser Lampe Privatbank AG | |
| 18.09.25 | Wolters Kluwer Neutral | UBS AG | |
| 18.09.25 | Novo Nordisk Neutral | UBS AG | |
| 18.09.25 | AB InBev Buy | UBS AG | |
| 18.09.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 18.09.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 18.09.25 | PUMA Underweight | JP Morgan Chase & Co. | |
| 18.09.25 | Nike Outperform | RBC Capital Markets |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.